Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Utah Medical Prod (UTMD)

Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Utah Medical Prod 7043 South 300 West Midvale UT 84047 USA

www.utahmed.com Employees: 167 P: 801-566-1200 F: 801-566-7305

Sector:

Medical

Description:

Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.

Key Statistics

Overview:

Market Capitalization, $K 217,275
Enterprise Value, $K 134,295
Shares Outstanding, K 3,204
Float, K 2,967
% Float 92.60%
Short Interest, K 101
Short Float 3.15%
Days to Cover 6.64
Short Volume Ratio 0.77
% of Insider Shareholders 7.40%
% of Institutional Shareholders 69.60%

Financials:

Annual Sales, $ 38,520 K
Annual Net Income, $ 11,290 K
Last Quarter Sales, $ 9,040 K
Last Quarter Net Income, $ 2,570 K
EBIT, $ 8,960 K
EBITDA, $ 16,440 K

Growth:

1-Year Return 11.60%
3-Year Return -22.17%
5-Year Return -19.64%
5-Year Revenue Growth -8.68%
5-Year Earnings Growth 16.00%
5-Year Dividend Growth 8.85%

Per-Share Information:

Most Recent Earnings 0.82 on 10/23/25
Next Earnings Date 05/05/26
Earnings Per Share ttm 3.48
EPS Growth vs. Prev Qtr -2.44%
EPS Growth vs. Prev Year -6.98%
Annual Dividend & Yield (Paid) 1.23 (1.81%)
Annual Dividend & Yield (Fwd) 1.24 (1.86%)
Most Recent Dividend 0.310 on 12/16/25
Next Ex-Dividends Date 03/17/26
Dividend Payable Date 04/03/26
Dividend Payout Ratio 35.08%

UTMD Ratios

Ratio
Price/Earnings ttm 19.13
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 9.60%
Return-on-Assets % 9.27%
Profit Margin % 29.31%
Debt/Equity 0.00
Price/Sales 5.54
Price/Cash Flow 13.50
Price/Book 1.80
Book Value/Share 36.84
Interest Coverage 0.00
60-Month Beta 0.34

UTMD Dividends

Date Value
12/16/25 $0.3100
09/17/25 $0.3050
06/16/25 $0.3050
03/14/25 $0.3050
12/16/24 $0.3050
09/20/24 $0.3000
06/14/24 $0.3000
03/14/24 $0.3000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar